Nuvilex (NASDAQ:PMCB) Shares Up 0.2% – What’s Next?

Nuvilex Inc. (NASDAQ:PMCB)’s share price shot up 0.2% during trading on Friday . The stock traded as high as $0.5712 and last traded at $0.5510. Approximately 131,483 shares traded hands during mid-day trading, an increase of 0% from the average daily volume of 131,438 shares. The stock had previously closed at $0.55.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded Nuvilex from a “sell (d)” rating to a “sell (e+)” rating in a research note on Monday, August 3rd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Nuvilex Stock Up 0.2%

The company has a market cap of $5.92 million, a P/E ratio of -0.18 and a beta of 0.57. The firm’s 50 day moving average is $0.67 and its two-hundred day moving average is $0.72.

About Nuvilex

PharmaCyte Biotech, Inc, a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. The company develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; and license agreements with SG Austria Pte.